Immune Checkpoint Inhibitors In Renal Cell Carcinoma
AUAUniversity31 Loka 2019

Immune Checkpoint Inhibitors In Renal Cell Carcinoma

Co-Host: William Huang, MD At the conclusion of these activities, participants will be able to: 1. Discuss the current immunotherapy options available for the treatment of RCC. 2. Describe both completed and accruing clinical trials that are defining the paradigms of immunotherapy use in RCC. 3. Identify and manage the adverse events related to these agents. CME Available: auau.auanet.org/node/26095 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma

Jaksot(426)

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
rss-narsisti
adhd-podi
psykopodiaa-podcast
rss-rahamania
rss-uskonto-on-tylsaa
rss-valo-minussa-2
rss-vapaudu-voimaasi
rss-duodecim-lehti
rss-niinku-asia-on
mielipaivakirja
rahapuhetta
aamukahvilla
ilona-rauhala
kesken
dear-ladies
rss-eron-alkemiaa
nakokulmia-rikollisuudesta-irrottautumiseen
rss-arkea-ja-aurinkoa-podcast-espanjasta